Joel Young

623 total citations
27 papers, 435 citations indexed

About

Joel Young is a scholar working on Psychiatry and Mental health, Cognitive Neuroscience and Clinical Psychology. According to data from OpenAlex, Joel Young has authored 27 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Psychiatry and Mental health, 7 papers in Cognitive Neuroscience and 6 papers in Clinical Psychology. Recurrent topics in Joel Young's work include Attention Deficit Hyperactivity Disorder (23 papers), Functional Brain Connectivity Studies (6 papers) and Neural and Behavioral Psychology Studies (4 papers). Joel Young is often cited by papers focused on Attention Deficit Hyperactivity Disorder (23 papers), Functional Brain Connectivity Studies (6 papers) and Neural and Behavioral Psychology Studies (4 papers). Joel Young collaborates with scholars based in United States, Canada and United Kingdom. Joel Young's co-authors include D. Wayne Goodman, C. Brendan Montano, Linda Wietecha, Gregory W. Mattingly, Elias Sarkis, Richard H. Weisler, Meihua Qiao, Joseph Gao, Liza Squires and Lenard A. Adler and has published in prestigious journals such as SHILAP Revista de lepidopterología, BMJ and Journal of the American Academy of Child & Adolescent Psychiatry.

In The Last Decade

Joel Young

25 papers receiving 414 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joel Young United States 13 372 182 88 46 43 27 435
Alexander Häge Germany 10 255 0.7× 132 0.7× 99 1.1× 46 1.0× 37 0.9× 27 348
Dayna Yorks United States 7 287 0.8× 123 0.7× 183 2.1× 31 0.7× 30 0.7× 7 403
Martin Gignac Canada 11 411 1.1× 155 0.9× 225 2.6× 44 1.0× 27 0.6× 21 509
T. Babcock United States 12 399 1.1× 201 1.1× 165 1.9× 27 0.6× 54 1.3× 28 491
Peter M. Wehmeier Germany 12 270 0.7× 152 0.8× 91 1.0× 28 0.6× 48 1.1× 24 322
Gregory Forehand United States 5 477 1.3× 182 1.0× 150 1.7× 67 1.5× 151 3.5× 7 541
Andrea Bilbow United Kingdom 6 452 1.2× 248 1.4× 152 1.7× 38 0.8× 63 1.5× 11 526
Bjørn Gjervan Norway 9 410 1.1× 198 1.1× 121 1.4× 17 0.4× 66 1.5× 14 445
Melissa Doffing United States 7 367 1.0× 145 0.8× 177 2.0× 73 1.6× 132 3.1× 8 456
Michal Goetz Czechia 13 242 0.7× 92 0.5× 104 1.2× 15 0.3× 61 1.4× 21 347

Countries citing papers authored by Joel Young

Since Specialization
Citations

This map shows the geographic impact of Joel Young's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel Young with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel Young more than expected).

Fields of papers citing papers by Joel Young

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel Young. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel Young. The network helps show where Joel Young may publish in the future.

Co-authorship network of co-authors of Joel Young

This figure shows the co-authorship network connecting the top 25 collaborators of Joel Young. A scholar is included among the top collaborators of Joel Young based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joel Young. Joel Young is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Mattingly, Gregory W., et al.. (2024). Efficacy of Viloxazine ER (Qelbree) for ADHD in Adults Based on Prior Stimulant Exposure. CNS Spectrums. 29(5). 490–491. 1 indexed citations
3.
4.
Crumley, Ellen, et al.. (2021). How is the medical assistance in dying (MAID) process carried out in Nova Scotia, Canada? A qualitative process model flowchart study. BMJ Open. 11(7). e048698–e048698. 12 indexed citations
5.
6.
Young, Joel & D. Wayne Goodman. (2016). Adult Attention-Deficit/Hyperactivity Disorder Diagnosis, Management, and Treatment in the <em>DSM-5</em> Era. The Primary Care Companion For CNS Disorders. 18(6). 34 indexed citations
7.
Wietecha, Linda, David B. Clemow, Andrew Buchanan, et al.. (2016). Atomoxetine Increased Effect over Time in Adults with Attention‐Deficit/Hyperactivity Disorder Treated for up to 6 Months: Pooled Analysis of Two Double‐Blind, Placebo‐Controlled, Randomized Trials. CNS Neuroscience & Therapeutics. 22(7). 546–557. 7 indexed citations
8.
9.
Wilens, Timothy E., Brigitte Robertson, Vanja Sikirica, et al.. (2015). A Randomized, Placebo-Controlled Trial of Guanfacine Extended Release in Adolescents With Attention-Deficit/Hyperactivity Disorder. Journal of the American Academy of Child & Adolescent Psychiatry. 54(11). 916–925.e2. 42 indexed citations
10.
Young, Joel. (2015). ADHD is a risk factor for premature death, Danish study shows. BMJ. 350(feb25 13). h1094–h1094. 3 indexed citations
11.
Young, Joel, Thomas A. Rugino, Ryan Dammerman, A. G. Lyne, & Jeffrey H. Newcorn. (2014). Efficacy of Guanfacine Extended Release Assessed During the Morning, Afternoon, and Evening Using a Modified Conners' Parent Rating Scale–Revised: Short Form. Journal of Child and Adolescent Psychopharmacology. 24(8). 435–441. 13 indexed citations
12.
Prevatt, Frances & Joel Young. (2014). Recognizing and Treating Attention-Deficit/Hyperactivity Disorder in College Students. Journal of College Student Psychotherapy. 28(3). 182–200. 12 indexed citations
13.
Mattingly, Gregory W., Richard H. Weisler, Joel Young, et al.. (2013). Clinical response and symptomatic remission in short- and long-term trials of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder. BMC Psychiatry. 13(1). 39–39. 30 indexed citations
14.
Young, Joel. (2013). Chronic Fatigue Syndrome: 3 Cases and a Discussion of the Natural History of Attention-Deficit/Hyperactivity Disorder. Postgraduate Medicine. 125(1). 162–168. 11 indexed citations
15.
Montano, C. Brendan & Joel Young. (2012). Discontinuity in the Transition from Pediatric to Adult Health Care for Patients with Attention–Deficit/Hyperactivity Disorder. Postgraduate Medicine. 124(5). 23–32. 34 indexed citations
16.
17.
Wietecha, Linda, Joel Young, Dustin Ruff, et al.. (2012). Atomoxetine Once Daily for 24 Weeks in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD). Clinical Neuropharmacology. 35(3). 125–133. 16 indexed citations
18.
Young, Joel, Elias Sarkis, Meihua Qiao, & Linda Wietecha. (2011). Once-Daily Treatment With Atomoxetine in Adults With Attention-Deficit/Hyperactivity Disorder. Clinical Neuropharmacology. 34(2). 51–60. 54 indexed citations
19.
Weisler, Richard H., Joel Young, Gregory W. Mattingly, et al.. (2009). Long-Term Safety and Effectiveness of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder. CNS Spectrums. 14(10). 573–586. 79 indexed citations
20.
Young, Joel. (2006). Treatment of Adult ADHD and Comorbid Disorders. CNS Spectrums. 11(S11). 10–12. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexander Häge Breakdown of academic impact, for papers by Dayna Yorks Breakdown of academic impact, for papers by Martin Gignac Breakdown of academic impact, for papers by T. Babcock Breakdown of academic impact, for papers by Peter M. Wehmeier Breakdown of academic impact, for papers by Gregory Forehand Breakdown of academic impact, for papers by Andrea Bilbow Breakdown of academic impact, for papers by Bjørn Gjervan Breakdown of academic impact, for papers by Melissa Doffing Breakdown of academic impact, for papers by Michal Goetz
Rankless by CCL
2026